Charles G. Phillips III, Director at NovoCure Ltd (NVCR), sold 50,000 shares at $30.30 ($1.5M) on 2018-05-25, disclosed to the SEC on 2018-05-30.
Open-market sale of $1.5M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2019-05-31 | $8.7M | — | Filing → |